Cargando…

GRK2 blockade with βARKct is essential for cardiac β(2)-adrenergic receptor signaling towards increased contractility

BACKGROUND: β(1)- and β(2)–adrenergic receptors (ARs) play distinct roles in the heart, e.g. β(1)AR is pro-contractile and pro-apoptotic but β(2)AR anti-apoptotic and only weakly pro-contractile. G protein coupled receptor kinase (GRK)-2 desensitizes and opposes βAR pro-contractile signaling by phos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salazar, Norma C, Vallejos, Ximena, Siryk, Ashley, Rengo, Giuseppe, Cannavo, Alessandro, Liccardo, Daniela, De Lucia, Claudio, Gao, Erhe, Leosco, Dario, Koch, Walter J, Lymperopoulos, Anastasios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846709/ https://www.ncbi.nlm.nih.gov/pubmed/23984976 http://dx.doi.org/10.1186/1478-811X-11-64

Ejemplares similares

Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapy
por: Cannavo, Alessandro, et al.
Publicado: (2013)

Targeting β(3)-Adrenergic Receptors in the Heart: Selective Agonism and β-Blockade
por: Cannavo, Alessandro, et al.
Publicado: (2017)

GRK2-Mediated Crosstalk Between β-Adrenergic and Angiotensin II Receptors Enhances Adrenocortical Aldosterone Production In Vitro and In Vivo
por: Pollard, Celina M., et al.
Publicado: (2020)

Genetic Catalytic Inactivation of GRK5 Impairs Cardiac Function in Mice Via Dysregulated P53 Levels
por: Marzano, Federica, et al.
Publicado: (2022)

Targeting GRK5 for Treating Chronic Degenerative Diseases
por: Marzano, Federica, et al.
Publicado: (2021)

Aldosterone Jeopardizes Myocardial Insulin and β-Adrenergic Receptor Signaling via G Protein-Coupled Receptor Kinase 2
por: Cannavo, Alessandro, et al.
Publicado: (2019)

Roles of GRK and PDE4 Activities in the Regulation of β(2) Adrenergic Signaling
por: Xin, Wenkuan, et al.
Publicado: (2008)

Sex/Gender- and Age-Related Differences in β-Adrenergic Receptor Signaling in Cardiovascular Diseases
por: Liccardo, Daniela, et al.
Publicado: (2022)

β-adrenergic receptor responsiveness in aging heart and clinical implications
por: Ferrara, Nicola, et al.
Publicado: (2014)

OR24-03 GRK2 Mediates Beta-Adrenergic Receptor Crosstalk to Enhanced Adrenocortical AngII-Dependent Aldosterone Production
por: Lymperopoulos, Anastasios, et al.
Publicado: (2020)

Myocardial GRK2 Reduces Fatty Acid Metabolism and β-Adrenergic Receptor-Mediated Mitochondrial Responses
por: Zhai, Ruxu, et al.
Publicado: (2022)

Suppression of adrenal βarrestin1-dependent aldosterone production by ARBs: head-to-head comparison
por: Dabul, Samalia, et al.
Publicado: (2015)

Physiology and pharmacology of the cardiovascular adrenergic system
por: Lymperopoulos, Anastasios
Publicado: (2013)

Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition
por: Maning, Jennifer, et al.
Publicado: (2020)

Carvedilol Selectively Stimulates βArrestin2-Dependent SERCA2a Activity in Cardiomyocytes to Augment Contractility
por: Maning, Jennifer, et al.
Publicado: (2022)

Gαs is dispensable for β-arrestin coupling but dictates GRK selectivity and is predominant for gene expression regulation by β2-adrenergic receptor
por: Burghi, Valeria, et al.
Publicado: (2023)

Current and future G protein-coupled receptor signaling targets for heart failure therapy
por: Siryk-Bathgate, Ashley, et al.
Publicado: (2013)

Pepducin-mediated cardioprotection via β-arrestin-biased β2-adrenergic receptor-specific signaling
por: Grisanti, Laurel A., et al.
Publicado: (2018)

Biased activation of β(2)-AR/Gi/GRK2 signal pathway attenuated β(1)-AR sustained activation induced by β(1)-adrenergic receptor autoantibody
por: Chen, Hao, et al.
Publicado: (2021)

β-arrestin 1 regulates β2-adrenergic receptor-mediated skeletal muscle hypertrophy and contractility
por: Kim, Jihee, et al.
Publicado: (2018)

β-Adrenergic Inhibition of Contractility in L6 Skeletal Muscle Cells
por: Öberg, Anette I., et al.
Publicado: (2011)

GRK5 is an essential co-repressor of the cardiac mineralocorticoid receptor and is selectively induced by finerenone
por: Pollard, Celina M, et al.
Publicado: (2022)

Deletion of Osteopontin Enhances β(2)-Adrenergic Receptor-Dependent Anti-Fibrotic Signaling in Cardiomyocytes
por: Pollard, Celina M., et al.
Publicado: (2019)

GRK5 is a regulator of fibroblast activation and cardiac fibrosis
por: Eguchi, Akito, et al.
Publicado: (2021)

Correction: Maning et al. Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition. Int. J. Mol. Sci. 2020, 21, 2868
por: Maning, Jennifer, et al.
Publicado: (2021)

Quantitative Modeling of GRK-Mediated β2AR Regulation
por: Vayttaden, Sharat J., et al.
Publicado: (2010)

The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist
por: Erickson, Catherine E., et al.
Publicado: (2013)

Myocardial pathology induced by aldosterone is dependent on non-canonical activities of G protein-coupled receptor kinases
por: Cannavo, Alessandro, et al.
Publicado: (2016)

Opioid Facilitation of β-Adrenergic Blockade: A New Pharmacological Condition?
por: Vamecq, Joseph, et al.
Publicado: (2015)

Sepsis-induced cardiac dysfunction and β-adrenergic blockade therapy for sepsis
por: Suzuki, Takeshi, et al.
Publicado: (2017)

Transforming Growth Factor β(1) Oppositely Regulates the Hypertrophic and Contractile Response to β-Adrenergic Stimulation in the Heart
por: Huntgeburth, Michael, et al.
Publicado: (2011)

Why Do We Not Assess Sympathetic Nervous System Activity in Heart Failure Management: Might GRK2 Serve as a New Biomarker?
por: Bencivenga, Leonardo, et al.
Publicado: (2021)

Structure–activity relationship study of angiotensin II analogs in terms of β‐arrestin‐dependent signaling to aldosterone production
por: Valero, Thairy Reyes, et al.
Publicado: (2016)

Insulin Inhibits Cardiac Contractility by Inducing a G(i)-Biased β(2)-Adrenergic Signaling in Hearts
por: Fu, Qin, et al.
Publicado: (2014)

Impaired desensitization of a human polymorphic α(2B)-adrenergic receptor variant enhances its sympatho-inhibitory activity in chromaffin cells
por: Nguyen, Kristy, et al.
Publicado: (2011)

Double life: How GRK2 and β-arrestin signaling participate in diseases
por: Zhai, Ruxu, et al.
Publicado: (2022)

NOX Inhibition Improves β-Adrenergic Stimulated Contractility and Intracellular Calcium Handling in the Aged Rat Heart
por: Valdés, Álvaro, et al.
Publicado: (2018)

β-adrenergic blockade attenuates cardiac dysfunction and myofibrillar remodelling in congestive heart failure
por: Machackova, Jarmila, et al.
Publicado: (2011)

β-Adrenergic blockade in patients with dementia and hip fracture is associated with decreased postoperative mortality
por: Ioannidis, Ioannis, et al.
Publicado: (2021)

β2-Adrenoceptors and GRK2 as Potential Biomarkers in Patients With Chronic Pulmonary Regurgitation
por: Rodriguez-Serrano, María, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1pvl20nceg2dgfngb8i7oka630